Richard Powell, MD
Internal Medicine · New Port Richey, FLNPI 1023103702
Payments from drug & device makers
Across 3,402 payments — averaging $2373.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$3.1M
- Janssen Research & Development, LLC$2.6M
- Johnson & Johnson$488K
- Roche Diagnostics Operations, Inc.$292K
- Seqirus USA Inc$268K
- Pfizer$250K
- plus $1M from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2,792 | $3,101,441 |
| Janssen Research & Development, LLC | 47 | $2,638,365 |
| Johnson & Johnson | 38 | $487,585 |
| Roche Diagnostics Operations, Inc. | 25 | $292,327 |
| Seqirus USA Inc | 212 | $268,310 |
| Pfizer | 35 | $249,602 |
| Bavarian Nordic A/s | 26 | $202,187 |
| AbbVie | 40 | $193,695 |
| Eisai Inc. | 82 | $163,188 |
| AstraZeneca | 7 | $146,735 |
| Astrazeneca UK Limited | 6 | $59,917 |
| Avanir Pharmaceuticals, Inc. | 11 | $59,707 |
| Amgen(2 entities) | 4 | $44,367 |
| OPKO Pharmaceuticals, LLC | 2 | $41,756 |
| Sanofi US Services Inc. | 18 | $37,741 |
| Boehringer Ingelheim | 3 | $19,389 |
| Swedish Orphan Biovitrum AB | 11 | $14,429 |
| Novo Nordisk AS | 8 | $13,876 |
| Bayer | 2 | $12,000 |
| Vertex | 3 | $10,191 |
| Novartis | 3 | $7,041 |
| GSK | 2 | $7,000 |
| Noven Pharmaceuticals, Inc. | 11 | $2,048 |
| Boehringer Ingelheim International GmbH | 2 | $1,623 |
| Biogen | 9 | $1,413 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Electromed, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$8,075,993 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New Port Richey
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.